List of Chapters/Sections(Table Of Content)
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pharmaceutical Intermediates Revenue
1.4 Market Analysis by Type
1.4.1 Global Pharmaceutical Intermediates Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 GMP
1.4.3 Non-GMP
1.5 Market by Application
1.5.1 Global Pharmaceutical Intermediates Market Share by Application: 2022-2027
1.5.2 Antibiotics
1.5.3 Antipyretic Analgesics
1.5.4 Vitamins
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Pharmaceutical Intermediates Market
1.8.1 Global Pharmaceutical Intermediates Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Pharmaceutical Intermediates Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Pharmaceutical Intermediates Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Pharmaceutical Intermediates Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Pharmaceutical Intermediates Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Pharmaceutical Intermediates Sales Volume Market Share by Region (2016-2021)
3.2 Global Pharmaceutical Intermediates Sales Revenue Market Share by Region (2016-2021)
3.3 North America Pharmaceutical Intermediates Sales Volume
3.3.1 North America Pharmaceutical Intermediates Sales Volume Growth Rate (2016-2021)
3.3.2 North America Pharmaceutical Intermediates Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia Pharmaceutical Intermediates Sales Volume
3.4.1 East Asia Pharmaceutical Intermediates Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Pharmaceutical Intermediates Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Pharmaceutical Intermediates Sales Volume (2016-2021)
3.5.1 Europe Pharmaceutical Intermediates Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Pharmaceutical Intermediates Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia Pharmaceutical Intermediates Sales Volume (2016-2021)
3.6.1 South Asia Pharmaceutical Intermediates Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Pharmaceutical Intermediates Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia Pharmaceutical Intermediates Sales Volume (2016-2021)
3.7.1 Southeast Asia Pharmaceutical Intermediates Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Pharmaceutical Intermediates Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East Pharmaceutical Intermediates Sales Volume (2016-2021)
3.8.1 Middle East Pharmaceutical Intermediates Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Pharmaceutical Intermediates Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa Pharmaceutical Intermediates Sales Volume (2016-2021)
3.9.1 Africa Pharmaceutical Intermediates Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Pharmaceutical Intermediates Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania Pharmaceutical Intermediates Sales Volume (2016-2021)
3.10.1 Oceania Pharmaceutical Intermediates Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Pharmaceutical Intermediates Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America Pharmaceutical Intermediates Sales Volume (2016-2021)
3.11.1 South America Pharmaceutical Intermediates Sales Volume Growth Rate (2016-2021)
3.11.2 South America Pharmaceutical Intermediates Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World Pharmaceutical Intermediates Sales Volume (2016-2021)
3.12.1 Rest of the World Pharmaceutical Intermediates Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Pharmaceutical Intermediates Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 North America
4.1 North America Pharmaceutical Intermediates Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Pharmaceutical Intermediates Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Pharmaceutical Intermediates Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Pharmaceutical Intermediates Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Pharmaceutical Intermediates Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Pharmaceutical Intermediates Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Pharmaceutical Intermediates Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Pharmaceutical Intermediates Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Pharmaceutical Intermediates Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Pharmaceutical Intermediates Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Pharmaceutical Intermediates Sales Volume Market Share by Type (2016-2021)
14.2 Global Pharmaceutical Intermediates Sales Revenue Market Share by Type (2016-2021)
14.3 Global Pharmaceutical Intermediates Sales Price by Type (2016-2021)
15 Consumption Analysis by Application
15.1 Global Pharmaceutical Intermediates Consumption Volume by Application (2016-2021)
15.2 Global Pharmaceutical Intermediates Consumption Value by Application (2016-2021)
16 Company Profiles and Key Figures in Pharmaceutical Intermediates Business
16.1 Lonza
16.1.1 Lonza Company Profile
16.1.2 Lonza Pharmaceutical Intermediates Product Specification
16.1.3 Lonza Pharmaceutical Intermediates Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 Catalent
16.2.1 Catalent Company Profile
16.2.2 Catalent Pharmaceutical Intermediates Product Specification
16.2.3 Catalent Pharmaceutical Intermediates Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 Patheon
16.3.1 Patheon Company Profile
16.3.2 Patheon Pharmaceutical Intermediates Product Specification
16.3.3 Patheon Pharmaceutical Intermediates Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 Jubilant
16.4.1 Jubilant Company Profile
16.4.2 Jubilant Pharmaceutical Intermediates Product Specification
16.4.3 Jubilant Pharmaceutical Intermediates Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 Granules
16.5.1 Granules Company Profile
16.5.2 Granules Pharmaceutical Intermediates Product Specification
16.5.3 Granules Pharmaceutical Intermediates Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 Ganesh
16.6.1 Ganesh Company Profile
16.6.2 Ganesh Pharmaceutical Intermediates Product Specification
16.6.3 Ganesh Pharmaceutical Intermediates Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.7 Chemcon
16.7.1 Chemcon Company Profile
16.7.2 Chemcon Pharmaceutical Intermediates Product Specification
16.7.3 Chemcon Pharmaceutical Intermediates Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.8 BASF
16.8.1 BASF Company Profile
16.8.2 BASF Pharmaceutical Intermediates Product Specification
16.8.3 BASF Pharmaceutical Intermediates Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.9 Porton
16.9.1 Porton Company Profile
16.9.2 Porton Pharmaceutical Intermediates Product Specification
16.9.3 Porton Pharmaceutical Intermediates Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.10 Lianhetech
16.10.1 Lianhetech Company Profile
16.10.2 Lianhetech Pharmaceutical Intermediates Product Specification
16.10.3 Lianhetech Pharmaceutical Intermediates Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.11 ABA Chem
16.11.1 ABA Chem Company Profile
16.11.2 ABA Chem Pharmaceutical Intermediates Product Specification
16.11.3 ABA Chem Pharmaceutical Intermediates Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.12 Tianma
16.12.1 Tianma Company Profile
16.12.2 Tianma Pharmaceutical Intermediates Product Specification
16.12.3 Tianma Pharmaceutical Intermediates Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.13 Jiujiujiu
16.13.1 Jiujiujiu Company Profile
16.13.2 Jiujiujiu Pharmaceutical Intermediates Product Specification
16.13.3 Jiujiujiu Pharmaceutical Intermediates Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.14 Alpha
16.14.1 Alpha Company Profile
16.14.2 Alpha Pharmaceutical Intermediates Product Specification
16.14.3 Alpha Pharmaceutical Intermediates Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.15 Jiuzhou
16.15.1 Jiuzhou Company Profile
16.15.2 Jiuzhou Pharmaceutical Intermediates Product Specification
16.15.3 Jiuzhou Pharmaceutical Intermediates Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.16 Yongtai
16.16.1 Yongtai Company Profile
16.16.2 Yongtai Pharmaceutical Intermediates Product Specification
16.16.3 Yongtai Pharmaceutical Intermediates Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 Pharmaceutical Intermediates Manufacturing Cost Analysis
17.1 Pharmaceutical Intermediates Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Pharmaceutical Intermediates
17.4 Pharmaceutical Intermediates Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Pharmaceutical Intermediates Distributors List
18.3 Pharmaceutical Intermediates Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Pharmaceutical Intermediates (2022-2027)
20.2 Global Forecasted Revenue of Pharmaceutical Intermediates (2022-2027)
20.3 Global Forecasted Price of Pharmaceutical Intermediates (2016-2027)
20.4 Global Forecasted Production of Pharmaceutical Intermediates by Region (2022-2027)
20.4.1 North America Pharmaceutical Intermediates Production, Revenue Forecast (2022-2027)
20.4.2 East Asia Pharmaceutical Intermediates Production, Revenue Forecast (2022-2027)
20.4.3 Europe Pharmaceutical Intermediates Production, Revenue Forecast (2022-2027)
20.4.4 South Asia Pharmaceutical Intermediates Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia Pharmaceutical Intermediates Production, Revenue Forecast (2022-2027)
20.4.6 Middle East Pharmaceutical Intermediates Production, Revenue Forecast (2022-2027)
20.4.7 Africa Pharmaceutical Intermediates Production, Revenue Forecast (2022-2027)
20.4.8 Oceania Pharmaceutical Intermediates Production, Revenue Forecast (2022-2027)
20.4.9 South America Pharmaceutical Intermediates Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World Pharmaceutical Intermediates Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of Pharmaceutical Intermediates by Application (2022-2027)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Pharmaceutical Intermediates by Country
21.2 East Asia Market Forecasted Consumption of Pharmaceutical Intermediates by Country
21.3 Europe Market Forecasted Consumption of Pharmaceutical Intermediates by Countriy
21.4 South Asia Forecasted Consumption of Pharmaceutical Intermediates by Country
21.5 Southeast Asia Forecasted Consumption of Pharmaceutical Intermediates by Country
21.6 Middle East Forecasted Consumption of Pharmaceutical Intermediates by Country
21.7 Africa Forecasted Consumption of Pharmaceutical Intermediates by Country
21.8 Oceania Forecasted Consumption of Pharmaceutical Intermediates by Country
21.9 South America Forecasted Consumption of Pharmaceutical Intermediates by Country
21.10 Rest of the world Forecasted Consumption of Pharmaceutical Intermediates by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer
